What impact have new minimal residual disease (MRD) assessment techniques had in myeloma?
Next-generation sequencing: revolutionising molecular diagnostics
Developments in prognostic factors of acute myeloid leukemia (AML)
Gert J. Ossenkoppele
Basic aspects of standard transplantation
Patient and physician perceptions on the symptomatic and economic burden of MPNs